Treatt PLC Reports Sharp Profit Drop in FY25 Amid Takeover Bid

On the face of it, leverage has increased, but the balance sheet still looks modestly geared. The buyback is notable in a down year: it signals capital discipline and confidence in long-term value, though it does leave the company slightly more indebted than last year.

Takeover update: recommended cash offer progressing

On 6 October 2025, Treatt published a circular regarding the recommended cash offer by Natara UK Bidco Limited, an entity controlled by funds managed by Exponent Private Equity LLP. The circular includes notices for a Court Meeting and a General Meeting to approve the transaction.

Key terms of the offer (such as the offer price or timetable) are not disclosed in this RNS. For shareholders, the next milestones are the meetings to vote on the deal. The publication of the circular suggests the process is ticking along as expected.

Forecast reaffirmed under Takeover Code Rule 28

In July, Treatt issued a profit forecast under Rule 28 of the Takeover Code: revenue of £130-135 million and PBTE of £9-11 million for FY25. The Board confirms this forecast remains valid, has been properly compiled on the stated assumptions, and is consistent with the Group’s existing accounting policies (UK-adopted International Accounting Standards).

Given today’s numbers fall neatly inside that range, investors should see this as management delivering (at least) on near-term expectations after a mid-year reset.

What’s driving the downdraft, and what could change?

Sustained high citrus oil prices

Heritage revenue fell 15%, and management again calls out elevated citrus oil prices. This is a double whammy: higher input costs and weaker customer demand for citrus-heavy formulations. A normalisation in citrus pricing would be a material tailwind for volumes and margins in this category.

North American demand softness

North America weakened as consumer confidence softened, dampening end-market demand. If US consumer sentiment stabilises or improves, Treatt’s beverage and flavour clients should resume more normal ordering patterns. That could help both Heritage and Premium in particular.

Operational discipline

Management emphasises cost control and execution. In practice, that should protect margins to a degree, but with revenue down nearly 15%, there is only so much opex discipline can do. The strategy remains sensible; the question is timing – when do category and regional headwinds ease?

Why this update matters for investors

• No new downgrade: Hitting the mid-year guidance range is helpful for credibility and reduces near-term forecast risk.
• Profitability reset: PBTE is down almost half year-on-year. Even in line with guidance, that is a meaningful reset of earnings power.
• Portfolio concentration: The mix was unchanged at 68% Heritage, so the business remains exposed to citrus dynamics. Diversification has not visibly shifted the dial in FY25.
• Balance sheet watch: Net debt moved up to £5.9 million, albeit after a £5 million buyback. Still manageable, but worth monitoring if trading stays soft.
• Takeover optionality: With a recommended cash offer on the table, the near-term equity story may hinge more on deal terms and timetable than on incremental trading news.

Key numbers at a glance

Metric	FY25 (c.)	FY24	Change
Revenue	£130.6m	£153.1m	Down £22.5m (approx. -14.7%)
PBTE (profit before tax & exceptionals)	£10.0m	£19.1m	Down £9.1m (approx. -47.6%)
Net debt (year end)	£5.9m	£0.7m	Up £5.2m (includes £5m buyback)
Revenue mix	Heritage 68%, Premium 23%, New 9%	Heritage 68%, Premium 23%, New 9%	Unchanged
Category sales trend	Heritage -15%, Premium -13%, New -17%	Not disclosed	All categories down

Positives and watch-outs from here

Positives

• Delivery within guidance reduces immediate forecast risk.
• Cost control and cash discipline helped fund a £5 million buyback while keeping net debt modest.
• Takeover process provides a potential near-term crystallisation event for shareholders.

Watch-outs

• Margin pressure persists with high citrus oil prices and weaker North American demand.
• Portfolio mix unchanged – exposure to citrus remains a key swing factor.
• Limited disclosure on FY25 margins, cash flow and outlook detail beyond the profit forecast – full-year results are still to come.

About Treatt: a quick refresher

Treatt is a global manufacturer and supplier of natural extracts and ingredients to the flavour, fragrance and consumer products industries, with particular strength in beverages. The Group employs around 350 people across Europe, North America and Asia, with manufacturing in the UK and US.

My take: a credible hold-the-line update while the deal looms

This is a straightforward, steady-the-ship announcement. The revenue and PBTE declines are stark, but there’s value in meeting the revised targets after July’s reset. The business is doing the right things operationally; the external backdrop (citrus pricing and US consumer demand) needs to improve for a cleaner recovery narrative.

In the near term, the recommended cash offer is likely to dominate the share price discussion. With the circular out and meetings to come, attention turns to deal approvals and terms (not disclosed here). If the transaction proceeds, investors will care less about incremental trading oscillations and more about the offer economics. If it doesn’t, then FY26 guidance, citrus normalisation and North American momentum become the key catalysts.

For now: expectations are under control, liquidity looks fine, and the strategic plan is unchanged. Not exciting, but credible in a difficult year.